Jynarque 90MG-30MG
Ended Awarded
- Contract number
- 36C24524N0514
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,560
Award facts
- Contract value 100% obligated
- $12,559.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
On April 10, 2024, the Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 90mg-30mg with a ceiling value of $12,559.90. This firm fixed-price delivery order, with an ultimate completion date of April 15, 2024, will be performed in Pittsburgh, Pennsylvania. The award was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize any set-aside designation, reflecting the vendor's status as an established large pharmaceutical manufacturer.
Jynarque (tolvaptan) is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. This delivery order is issued against Otsuka America Pharmaceutical Inc.'s larger Indefinite Delivery Vehicle—specifically a Blanket Purchase Agreement valued at $83.3 million awarded by the VA's National Acquisition Center with completion through March 26, 2026—which streamlines procurement of critical pharmaceutical treatments across multiple VA Integrated Service Networks. The company maintains significant federal supply schedule contracts totaling approximately $396 million, demonstrating established capability to support the VA's mission of providing specialized pharmaceutical treatments to veterans nationwide.
Quick answers
Who was awarded contract 36C24524N0514?
36C24524N0514 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 10, 2024.
How much is contract 36C24524N0514 worth?
The government has obligated $12,560 on 36C24524N0514.
Is contract 36C24524N0514 an order under another contract?
Yes. 36C24524N0514 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0514 competed?
The extent of competition for 36C24524N0514 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award